106 related articles for article (PubMed ID: 30058590)
1. Pseudohypoaldosteronism Type II Caused by
Wang Q; Cao BY; Su C; Li WJ; Gong CX
Chin Med J (Engl); 2018 Aug; 131(15):1879-1881. PubMed ID: 30058590
[No Abstract] [Full Text] [Related]
2. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
Yoshida S; Araki Y; Mori T; Sasaki E; Kasagi Y; Isobe K; Susa K; Inoue Y; Bomont P; Okado T; Rai T; Uchida S; Sohara E
Clin Exp Nephrol; 2018 Dec; 22(6):1251-1257. PubMed ID: 29869755
[TBL] [Abstract][Full Text] [Related]
3. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
Schumacher FR; Siew K; Zhang J; Johnson C; Wood N; Cleary SE; Al Maskari RS; Ferryman JT; Hardege I; Yasmin ; Figg NL; Enchev R; Knebel A; O'Shaughnessy KM; Kurz T
EMBO Mol Med; 2015 Oct; 7(10):1285-306. PubMed ID: 26286618
[TBL] [Abstract][Full Text] [Related]
4. Familial cases of pseudohypoaldosteronism type II harboring a novel mutation in the Cullin 3 gene.
Nakano K; Kubota Y; Mori T; Chiga M; Mori T; Sonoda S; Ueda D; Asakura I; Ikegaya T; Kagawa J; Uchida S; Kubota A
Nephrology (Carlton); 2020 Nov; 25(11):818-821. PubMed ID: 32619053
[TBL] [Abstract][Full Text] [Related]
5. A young child with pseudohypoaldosteronism type II by a mutation of Cullin 3.
Tsuji S; Yamashita M; Unishi G; Takewa R; Kimata T; Isobe K; Chiga M; Uchida S; Kaneko K
BMC Nephrol; 2013 Jul; 14():166. PubMed ID: 23902721
[TBL] [Abstract][Full Text] [Related]
6. Cullin 3 and Blood Pressure Regulation: Insights From Familial Hyperkalemic Hypertension.
Maeoka Y; Cornelius RJ; McCormick JA
Hypertension; 2023 May; 80(5):912-923. PubMed ID: 36861484
[TBL] [Abstract][Full Text] [Related]
7. Pseudohypoaldosteronism type 2: CUL3 mutation confirmed 15 years following initial diagnosis.
Li B; Soule S; Wilkinson T; Florkowski C
Intern Med J; 2022 Apr; 52(4):691-692. PubMed ID: 35419964
[No Abstract] [Full Text] [Related]
8. A case of novel mutation of Cullin 3 gene in pseudohypoaldosteronism type II.
Wang L; Nie M; Guo F; Tian Z; Guo X; Zhang S
J Hypertens; 2022 Jun; 40(6):1239-1242. PubMed ID: 35703886
[TBL] [Abstract][Full Text] [Related]
9. CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy.
Osawa M; Ogura Y; Isobe K; Uchida S; Nonoyama S; Kawaguchi H
Pediatr Nephrol; 2013 Sep; 28(9):1881-4. PubMed ID: 23689903
[TBL] [Abstract][Full Text] [Related]
10. Familial Hyperkalemic Hypertension Genotype With a Negative Phenotype: A CUL3 Mosaicism.
Ostrosky-Frid M; Chávez-Canales M; Romo M; Grunfeld B; Simsolo R; Segura-Kato Y; Tusié-Luna T; Gamba G
Am J Hypertens; 2020 Mar; 33(3):278-281. PubMed ID: 31802109
[No Abstract] [Full Text] [Related]
11. Pseudohypoaldosteronism types I and II: little more than a name in common.
Casas-Alba D; Vila Cots J; Monfort Carretero L; Martorell Sampol L; Zennaro MC; Jeunemaitre X; Camacho Díaz JA
J Pediatr Endocrinol Metab; 2017 May; 30(5):597-601. PubMed ID: 28593901
[TBL] [Abstract][Full Text] [Related]
12. [KLHL3 and CULLIN-3: new genes involved in familial hypertension].
Louis-Dit-Picard H; Hadchouel J; Jeunemaitre X
Med Sci (Paris); 2012; 28(8-9):703-6. PubMed ID: 22920870
[No Abstract] [Full Text] [Related]
13. Mutant Cullin causes cardiovascular compromise.
Luft FC
EMBO Mol Med; 2015 Oct; 7(10):1254-6. PubMed ID: 26294796
[TBL] [Abstract][Full Text] [Related]
14. Decrease of WNK4 ubiquitination by disease-causing mutations of KLHL3 through different molecular mechanisms.
Mori Y; Wakabayashi M; Mori T; Araki Y; Sohara E; Rai T; Sasaki S; Uchida S
Biochem Biophys Res Commun; 2013 Sep; 439(1):30-4. PubMed ID: 23962426
[TBL] [Abstract][Full Text] [Related]
15. Regulation of blood pressure and renal electrolyte balance by Cullin-RING ligases.
Uchida S
Curr Opin Nephrol Hypertens; 2014 Sep; 23(5):487-93. PubMed ID: 24992566
[TBL] [Abstract][Full Text] [Related]
16. [Severity of familial hyperkalemic hypertension caused by CUL-3 mutations: a story about kidneys and blood vessels].
Rafael C; Hadchouel J
Med Sci (Paris); 2020 May; 36(5):455-458. PubMed ID: 32452365
[No Abstract] [Full Text] [Related]
17. Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.
Zhang C; Meermeier NP; Terker AS; Blankenstein KI; Singer JD; Hadchouel J; Ellison DH; Yang CL
Biochem Biophys Res Commun; 2016 Jan; 469(1):44-48. PubMed ID: 26607111
[TBL] [Abstract][Full Text] [Related]
18. Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.
Sharma P; Chatrathi HE
Cell Commun Signal; 2023 Oct; 21(1):286. PubMed ID: 37845702
[TBL] [Abstract][Full Text] [Related]
19. A novel mutation in exon 9 of Cullin 3 gene contributes to aberrant splicing in pseudohypoaldosteronism type II.
Shao L; Cui L; Lu J; Lang Y; Bottillo I; Zhao X
FEBS Open Bio; 2018 Mar; 8(3):461-469. PubMed ID: 29511623
[TBL] [Abstract][Full Text] [Related]
20. [Gordon syndrome: The importance of measuring blood pressure in children].
Bruel A; Vargas-Poussou R; Jeunemaitre X; Labbe A; Merlin E; Bessenay L
Arch Pediatr; 2016 Aug; 23(8):827-31. PubMed ID: 27369102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
